Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Therapeutic Proteins Market Global Briefing 2017

Therapeutic Proteins Market Global Briefing 2017

From $1,000.00

Including: Murine Mabs, Chimeric Mabs, Humanized Mabs, And Human Mabs, In Vivo Monoclonal Antibodies And In Vitro Monoclonal Antibodies.
Covering: Amgen, Abbvie, Sanofi AG, F. Hoffmann-La Roche Ltd.

Clear selection
SKU: 2218. Category: .

Therapeutic Proteins Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global therapeutic proteins market.


The Therapeutic Proteins Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The therapeutic proteins market is one of the segments in the biologics market, within the healthcare market.

The market characteristics section of the report defines and explains the market.

The market size section gives the therapeutic proteins market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the therapeutic proteins market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the therapeutic proteins market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.


Markets Covered: Monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products.

Companies Mentioned: F. Hoffmann-La Roche Ltd., Amgen, Novo Nordisk.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Monoclonal Antibodies (MAbS) Market Global Briefing 2017
Vaccines Market Global Briefing 2017

Table Of Contents
1. Introduction
2. Therapeutic Proteins Market Characteristics
3. Therapeutic Proteins Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Therapeutic Proteins Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Therapeutic Proteins Market Geography Split
6. Therapeutic Proteins Market As A Proportion of Biologics Market, 2016, By Region
7. Therapeutic Proteins Market As A Proportion of Biologics Market, 2016, By Country
8. Therapeutic Proteins Market Segmentation
9. Therapeutic Proteins Competitive Landscape
F. Hoffmann-La Roche Ltd.
Novo Nordisk
10. Key Mergers And Acquisitions In The Therapeutic Proteins Market
11. Therapeutic Proteins Market Trends And Strategies
NAICS Definitions of Industry Covered In This Report
Research Methodology
Market Numbers
Competitor Market Share Data
Verification Through Expert Interviews
Note on Currency Conversions
Research Inquiries
The Business Research Company
Executive Summary
The therapeutic proteins market covers proteins that are used for the treatment of various diseases such as diabetes, cancer, infectious diseases, hemophilia, anemia, Multiple Sclerosis, hepatitis B/C, and other diseases. This market has five major product segments: monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products.

The global therapeutic proteins market was estimated to be around $90 billion as of 2016. The global therapeutic proteins made up around 43% of the overall biologics market in 2016. The therapeutic proteins market was the largest market in the global biologics market in 2016.

Product Approval
Increase in number of therapeutic protein drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in June 2017, Roche Diagnostics received FDA approval for its Rituxan Hycela injection formulation for its commercialization in the US market. The treatment includes intravenous rituximab (Rituxan) in combination with hyaluronidase human that is delivered under the skin. It is used in the treatment of chronic lymphocytic leukemia.
Get Customized Report
Please fill in your details. Our team will get back to you